Dimercaprol
FDA-approved product (injectable, injection), marketed as Bal.
- Registered studies
- 50+
- Lab records
- 0
- Pathogens at ≥40%
- 0 of 4
Chemical structure
Existing / approved use
Documented · FDA, WHO, ChEMBLNo approved indication recorded
ChEMBL records no approved indication for Dimercaprol. Its therapeutic class is shown instead.
- WHO therapeutic group
- Antidotes
- Anti-infective classification
- Not classified as an anti-infective.
Repurposing investigation
No supported pathogen reaches ≥40% AI-predicted activity for Dimercaprol, so it is not among the repurposing candidates. Its predictions are shown below.
AI-predicted activity
AI prediction · nothing measured- MRSA15.7% AI-predicted activityBelow the ≥40% mark this site uses to surface candidates.
- E. coli13.3% AI-predicted activityBelow the ≥40% mark this site uses to surface candidates.
- K. pneumoniae8.8% AI-predicted activityBelow the ≥40% mark this site uses to surface candidates.
- M. tuberculosis16.7% AI-predicted activityBelow the ≥40% mark this site uses to surface candidates.
A model’s estimate of laboratory activity against each pathogen species. It is not clinical effectiveness.
Evidence
Clinical and experimental
Documented evidenceClinical
50+registered studies name this medicine, for any condition. The registry search keeps the first 50, so there may be more. See them below.
Experimental
No evidence found
No laboratory measurement against the four pathogens in the ChEMBL records loaded here.
Docking
Computational · nothing measuredDihydrofolate reductase ↗ (E. coli)
Not yet docked: queued in the docking rundetails
KPC-2 carbapenemase ↗ (K. pneumoniae)
Not yet docked: queued in the docking rundetails
Enoyl-ACP reductase (InhA) ↗ (M. tuberculosis)
Not yet docked: queued in the docking rundetails
Dihydrofolate reductase ↗ (MRSA)
Not yet docked: queued in the docking rundetails
AutoDock Vina, one experimentally solved protein per pathogen. This project’s screening target is -7.0 kcal/mol, its own mark rather than a universal cutoff. A docking score is a structural hypothesis, not proof of binding, and requires experimental validation.
Other medicines to investigate
AI prediction · nothing measuredOther repurposing candidates: approved medicines besides Dimercaprol with AI-predicted activity ≥40% against the chosen pathogen, leaving out existing antimicrobials. They are computational candidates for further investigation, not alternatives and not recommendations.
Sorted by AI-predicted activity, high to low. The order is not a ranking of which medicine is better.
- FurazolidoneExisting use: Other antiinfectives and antiseptics91.4% AI-predicted activityagainst M. tuberculosisLab records exist49 registered studies
- TriflupromazineExisting use: Psychosis90.6% AI-predicted activityagainst M. tuberculosisNo documented evidence found
- ValdecoxibExisting use: Dysmenorrhea, Osteoarthritis, Rheumatic disease and 1 more88.6% AI-predicted activityagainst M. tuberculosisLab records exist31 registered studies
- CelecoxibExisting use: Ankylosing spondylitis, Cancer, Colorectal neoplasm and 15 more87.6% AI-predicted activityagainst M. tuberculosisLab records exist50+ registered studies
- Dorzolamide HydrochlorideExisting use: Glaucoma, Ocular hypertension, Open-angle glaucoma86.8% AI-predicted activityagainst M. tuberculosisLab records exist50+ registered studies
- MethazolamideExisting use: Glaucoma, Open-angle glaucoma85.6% AI-predicted activityagainst M. tuberculosisLab records exist11 registered studies
- AcetazolamideExisting use: Altitude sickness, Angle-closure glaucoma, Congestive heart failure and 5 more85.2% AI-predicted activityagainst M. tuberculosisLab records exist50+ registered studies
- Trifluoperazine HydrochlorideExisting use: Anxiety disorder, Mental or behavioural disorder, Psychosis and 1 more84.6% AI-predicted activityagainst M. tuberculosis1 registered study
- TriclosanExisting use: Phenol and derivatives, Medicated dressings with antiinfectives84.2% AI-predicted activityagainst M. tuberculosisLab records exist50+ registered studies
- NitrofurazoneExisting use: Eye infection, Leishmaniasis, Trypanosomiasis84.0% AI-predicted activityagainst M. tuberculosis8 registered studies
- BrinzolamideExisting use: Glaucoma, Ocular hypertension, Open-angle glaucoma83.8% AI-predicted activityagainst M. tuberculosisLab records exist50+ registered studies
- ZonisamideExisting use: Epilepsy, Focal-onset seizure, Partial epilepsy and 1 more82.8% AI-predicted activityagainst M. tuberculosisLab records exist50+ registered studies
Registered studies
A registration describes a study; it does not establish a positive result.
Reusable Flexible Bronchoscopes Versus Single Use Bronchoscopes : a Satisfaction Survey
NCT03392610 · start 2017-10-01
Registered record
- Registry ID
- NCT03392610
- Conditions
- Bronchoscope Users
- Interventions
- Not recorded
- Study type
- OBSERVATIONAL
- Phase
- Not recorded
- Registry status
- Unknown
- Start
- 2017-10-01
- Completion
- 2019-06-30
- Enrolment
- 500
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionBronchoscope UsersInterventionNot recordedPhaseNot recordedRegistry statusUnknownMicrobiota and the Lung Cancer
NCT03068663 · start 2017-05-23
Registered record
- Registry ID
- NCT03068663
- Conditions
- Non Small Cell Lung Cancer
- Interventions
- Sampling
- Study type
- INTERVENTIONAL
- Phase
- Not applicable
- Registry status
- Active not recruiting
- Start
- 2017-05-23
- Completion
- 2029-10-30
- Enrolment
- 40
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionNon Small Cell Lung CancerInterventionSamplingPhaseNot applicableRegistry statusActive not recruitingChanges in Alveolar Macrophage Function During Acute Lung Injury
NCT02693912 · start 2016-09
Registered record
- Registry ID
- NCT02693912
- Conditions
- Acute Lung Injury
- Interventions
- Bronchoscopy
- Study type
- OBSERVATIONAL
- Phase
- Not recorded
- Registry status
- Unknown
- Start
- 2016-09
- Completion
- 2018-08
- Enrolment
- 25
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionAcute Lung InjuryInterventionBronchoscopyPhaseNot recordedRegistry statusUnknownChange in Management Following Bronchoscopy in Hematopoietic Stem Cell Transplant Patients With Pulmonary Infiltrates
NCT04998903 · start 2016-05-01
Registered record
- Registry ID
- NCT04998903
- Conditions
- Stem Cell Transplant Complications; Pulmonary Complication
- Interventions
- Fiberoptic Bronchoscopy
- Study type
- OBSERVATIONAL
- Phase
- Not recorded
- Registry status
- Completed
- Start
- 2016-05-01
- Completion
- 2020-02-27
- Enrolment
- 51
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionStem Cell Transplant Complications; Pulmonary ComplicationInterventionFiberoptic BronchoscopyPhaseNot recordedRegistry statusCompletedGLASSIA Safety, Immunogenicity, and Bronchoalveolar Lavage Study
NCT02525861 · start 2016-03-08
Registered record
- Registry ID
- NCT02525861
- Conditions
- Alpha1-antitrypsin Deficiency
- Interventions
- GLASSIA
- Study type
- INTERVENTIONAL
- Phase
- Phase 3
- Registry status
- Completed
- Start
- 2016-03-08
- Completion
- 2020-07-29
- Enrolment
- 34
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionAlpha1-antitrypsin DeficiencyInterventionGLASSIAPhasePhase 3Registry statusCompletedEffects of Permissive Hypercapnia During Lung Surgery on Inflammatory Biomarkers in Serum and Bronchoalveolar Lavage Fluid
NCT07749456 · start 2015-06-01
Registered record
- Registry ID
- NCT07749456
- Conditions
- Thoracic Surgery
- Interventions
- Allowed permissive hypercapnia
- Study type
- INTERVENTIONAL
- Phase
- Not applicable
- Registry status
- Completed
- Start
- 2015-06-01
- Completion
- 2026-02-28
- Enrolment
- 40
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionThoracic SurgeryInterventionAllowed permissive hypercapniaPhaseNot applicableRegistry statusCompletedStudy of Different Etiologic Diagnostic Methods in Ventilator Associated Pneumonia (VAP)
NCT02363023 · start 2015-06
Registered record
- Registry ID
- NCT02363023
- Conditions
- Ventilator Associated Pneumonia
- Interventions
- Collect tracheal and pulmonary secretions
- Study type
- OBSERVATIONAL
- Phase
- Not recorded
- Registry status
- Terminated
- Start
- 2015-06
- Completion
- 2016-06
- Enrolment
- 30
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionVentilator Associated PneumoniaInterventionCollect tracheal and pulmonary secretionsPhaseNot recordedRegistry statusTerminatedCardiopulmonary Effects of Bronchoalveolar Wash on Patients With Acute Respiratory Distress Syndrome
NCT02818049 · start 2015-02-06
Registered record
- Registry ID
- NCT02818049
- Conditions
- Bronchioalveolar Lavage
- Interventions
- Bronchoalveolar Lavage
- Study type
- INTERVENTIONAL
- Phase
- Not applicable
- Registry status
- Terminated
- Start
- 2015-02-06
- Completion
- 2018-02-06
- Enrolment
- 24
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionBronchioalveolar LavageInterventionBronchoalveolar LavagePhaseNot applicableRegistry statusTerminatedLung Microbiome and Inflammation in Early COPD
NCT02777879 · start 2014-05
Registered record
- Registry ID
- NCT02777879
- Conditions
- Chronic Obstuctive Pulmonary Disease
- Interventions
- Bronchoscopy
- Study type
- OBSERVATIONAL
- Phase
- Not recorded
- Registry status
- Recruiting
- Start
- 2014-05
- Completion
- 2030-08
- Enrolment
- 230
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionChronic Obstuctive Pulmonary DiseaseInterventionBronchoscopyPhaseNot recordedRegistry statusRecruitingComparison of Characteristics of Bronchoalveolar Lavage Dusting and of Specific Questionnary Data in Healthy Volunteers and Patients Suffering From Sarcoidosis
NCT02863406 · start 2014-02
Registered record
- Registry ID
- NCT02863406
- Conditions
- Sarcoidosis
- Interventions
- Bronchoalveolar lavage
- Study type
- INTERVENTIONAL
- Phase
- Not applicable
- Registry status
- Completed
- Start
- 2014-02
- Completion
- 2015-07
- Enrolment
- 40
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionSarcoidosisInterventionBronchoalveolar lavagePhaseNot applicableRegistry statusCompletedIdentification and Characterization of Bacteria in the Lungs of Children From 6 Months up to 6 Years Old, With Suspected Infection of the Lungs, in Spain.
NCT02838407 · start 2013-09-23
Registered record
- Registry ID
- NCT02838407
- Conditions
- Infections, Streptococcal
- Interventions
- BAL fluid sampling; Nasopharyngeal swab sampling
- Study type
- INTERVENTIONAL
- Phase
- Not applicable
- Registry status
- Completed
- Start
- 2013-09-23
- Completion
- 2015-09-23
- Enrolment
- 197
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionInfections, StreptococcalInterventionBAL fluid sampling; Nasopharyngeal swab samplingPhaseNot applicableRegistry statusCompletedStudy on the Influence of Fluoroscopy in the Diagnosis of Peripheral Lung Lesions With Endobronchial Ultrasound Guidance
NCT01863836 · start 2013-04
Registered record
- Registry ID
- NCT01863836
- Conditions
- Peripheral Pulmonary Lesions
- Interventions
- Fluoroscopy; Radial EBUS-guided biopsy
- Study type
- INTERVENTIONAL
- Phase
- Not applicable
- Registry status
- Completed
- Start
- 2013-04
- Completion
- 2015-04
- Enrolment
- 133
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionPeripheral Pulmonary LesionsInterventionFluoroscopy; Radial EBUS-guided biopsyPhaseNot applicableRegistry statusCompletedBronchoalveolar Lavage Lateral-Flow Device Test for Invasive Pulmonary Aspergillosis: a Multicenter Study
NCT02058316 · start 2013-02
Registered record
- Registry ID
- NCT02058316
- Conditions
- Invasive Pulmonary Aspergillosis
- Interventions
- Lateral Flow Device Test
- Study type
- OBSERVATIONAL
- Phase
- Not recorded
- Registry status
- Completed
- Start
- 2013-02
- Completion
- 2019-02
- Enrolment
- 350
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionInvasive Pulmonary AspergillosisInterventionLateral Flow Device TestPhaseNot recordedRegistry statusCompletedDetecting Respiratory Viruses in Upper and Lower Respiratory Tract Samples
NCT01597089 · start 2012-09-01
Registered record
- Registry ID
- NCT01597089
- Conditions
- Respiratory Viruses
- Interventions
- Not recorded
- Study type
- OBSERVATIONAL
- Phase
- Not recorded
- Registry status
- Terminated
- Start
- 2012-09-01
- Completion
- 2018-05-01
- Enrolment
- 35
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionRespiratory VirusesInterventionNot recordedPhaseNot recordedRegistry statusTerminatedDiagnostic Study of Combined Biomnarker Testing in Bronchoalveolar Lavage Samples of Immunocompromised Patients
NCT01695512 · start 2012-08
Registered record
- Registry ID
- NCT01695512
- Conditions
- Invasive Aspergillosis; Acute Leukemia; Biomarkers; Stem Cell Transplantation
- Interventions
- Not recorded
- Study type
- OBSERVATIONAL
- Phase
- Not recorded
- Registry status
- Unknown
- Start
- 2012-08
- Completion
- 2020-12
- Enrolment
- 200
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionInvasive Aspergillosis; Acute Leukemia; Biomarkers; Stem Cell TransplantationInterventionNot recordedPhaseNot recordedRegistry statusUnknown